首站-论文投稿智能助手
典型文献
Potential significance of CX3CR1 dynamics in stress resilience against neuronal disorders
文献摘要:
Recent findings have implicated inflammatory responses in the central nervous system in a variety of neuropsychiatric and neurodegenerative diseases, and the understanding and control of immunological responses could be a major factor of future therapeutic strategies for neurological disorders. Microglia, derived from myelogenous cells, respond to a number of stimuli and make immune responses, resulting in a prominent role as cells that act on inflammation in the central nervous system. Fractalkine (FKN or CX3CL1) signaling is an important factor that influences the inflammatory response of microglia. The receptor for FKN, CX3CR1, is usually expressed in microglia in the brain, and therefore the inflammatory response of microglia is modified by FKN. Reportedly, FKN often suppresses inflammatory responses in microglia and activation of its receptor may be effective in the treatment of inflammatory neurological disorders. However, it has also been suggested that inflammatory responses facilitated by FKN signaling aggravate neurological disorders. Thus, further studies are still required to resolve the conflicting interpretation of the protective or deleterious contribution of microglial FKN signaling. Yet notably, regulation of FKN signaling has recently been shown to be beneficial in the treatment of human diseases, although not neurological diseases. In addition, a CX3CR1 inhibitor has been developed and successfully tested in animal models, and it is expected to be in human clinical trials in the future. In this review, I describe the potential therapeutic consideration of microglial CX3CR1 dynamics through altered FKN signaling.
文献关键词:
作者姓名:
Koichi Inoue
作者机构:
Department of Integrative Anatomy,Nagoya City University Graduate School of Medical Sciences,Nagoya,Japan
引用格式:
[1]Koichi Inoue-.Potential significance of CX3CR1 dynamics in stress resilience against neuronal disorders)[J].中国神经再生研究(英文版),2022(10):2153-2156
A类:
Reportedly
B类:
Potential,significance,CX3CR1,dynamics,stress,resilience,against,neuronal,disorders,Recent,findings,have,implicated,inflammatory,responses,central,nervous,system,variety,neuropsychiatric,neurodegenerative,diseases,understanding,control,immunological,could,major,future,therapeutic,strategies,neurological,Microglia,derived,from,myelogenous,cells,respond,number,stimuli,make,immune,resulting,prominent,role,that,inflammation,Fractalkine,FKN,CX3CL1,signaling,important,influences,receptor,usually,expressed,brain,therefore,modified,by,often,suppresses,activation,its,may,effective,treatment,However,has,also,been,suggested,facilitated,aggravate,Thus,further,studies,are,still,required,resolve,conflicting,interpretation,protective,deleterious,contribution,microglial,Yet,notably,regulation,recently,shown,beneficial,human,although,In,addition,inhibitor,developed,successfully,tested,animal,models,expected,clinical,trials,this,review,describe,potential,consideration,through,altered
AB值:
0.528517
相似文献
CX3C-chemokine receptor 1 modulates cognitive dysfunction induced by sleep deprivation
Xin Jiawei;Wang Chao;Cheng Xiaojuan;Xie Changfu;Zhang Qiuyang;Ke Yilang;Huang Xuanyu;Chen Xiaochun;Pan Xiaodong-Department of Neurology, Fujian Institute of Geriatrics, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, China;Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, Fuzhou, Fujian 350001, China;Key Laboratory of Brain Aging and Neurodegenerative Diseases, Fujian Medical University, Fuzhou, Fujian 350001, China;School and Hospital of Stomatology, Fujian Medical University, Fuzhou, Fujian 350001, China;Department of Geriatrics, Fujian Institute of Geriatrics, Fujian Medical University Union Hospital, Fuzhou, Fujian 350001, China;Fujian Key Laboratory of Vascular Aging, Fujian Medical University, Fuzhou, Fujian 350001, China
Inhibiting Hv1 channel in peripheral sensory neurons attenuates chronic inflammatory pain and opioid side effects
Qiansen Zhang;Yimin Ren;Yiqing Mo;Peipei Guo;Ping Liao;Yuncheng Luo;Jie Mu;Zhuo Chen;Yang Zhang;Ya Li;Linghui Yang;Daqing Liao;Jie Fu;Juwen Shen;Wei Huang;Xuewen Xu;Yanyan Guo;Lianghe Mei;Yunxia Zuo;Jin Liu;Huaiyu Yang;Ruotian Jiang-Shanghai Key Laboratory of Regulatory Biology,Institute of Biomedical Sciences,School of Life Sciences,East China Normal University,Shanghai,China;Laboratory of Anesthesia and Critical Care Medicine,National-Local Joint Engineering Research Center of Translational Medicine of Anesthesiology,West China Hospital,Sichuan University,Chengdu,Sichuan,China;Department of Anesthesiology,the Affiliated Hospital of Guizhou Medical University,Guiyang,Guizhou,China;Department of Integrated Traditional Chinese and Western Medicine,Sichuan Provincial Pancreatitis Centre and West China-Liverpool Biomedical Research Centre,West China Hospital,Sichuan University,Chengdu,Sichuan,China;Department of Burn and Plastic Surgery,West China Hospital of Sichuan University,Chengdu,Sichuan,China;Suzhou Institute of Drug Innovation,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Suzhou,Jiangsu,China
Chalcone derivatives ameliorate lipopolysaccharide-induced acute lung injury and inflammation by targeting MD2
Ya-li Zhang;Wen-xin Zhang;Jue-qian Yan;Ye-lin Tang;Wen-jing Jia;Zheng-wei Xu;Ming-jiang Xu;Nipon Chattipakorn;Yi Wang;Jian-peng Feng;Zhi-guo Liu;Guang Liang-Chemical Biology Research Center,School of Pharmaceutical Sciences,Wenzhou Medical University,Wenzhou 325035,China;Key Laboratory of Molecular Pharmacology and Drug Evaluation(Yantai University),Ministry of Education,Yantai University,Yantai 264005,China;School of Pharmaceutical Sciences,Hangzhou Medical College,Hangzhou 311399,China;Zhuji Biomedicine Institute,School of Pharmaceutical Sciences,Wenzhou Medical University,Zhuji 311800,China;Cardiac Electrophysiology Research and Training Center,Faculty of Medicine,Chiang Mai University,Chiang Mai 50200,Thailand;Wenzhou Institute,University of Chinese Academy of Sciences,Wenzhou 325001,China
Pharmacological inhibition of MyD88 suppresses inflammation in tubular epithelial cells and prevents diabetic nephropathy in experimental mice
Qiu-yan Zhang;Su-jing Xu;Jian-chang Qian;Li-bin Yang;Peng-qin Chen;Yi Wang;Xiang Hu;Ya-li Zhang;Wu Luo;Guang Liang-Chemical Biology Research Center,School of Pharmaceutical Sciences,Wenzhou Medical University,Wenzhou 325035,China;Medical Research Center,The First Affiliated Hospital,Wenzhou Medical University,Wenzhou 325035,China;School and Hospital of Stomatology,Wenzhou Medical University,Wenzhou 325027,China;Department of Endocrinology,The First Affiliated Hospital,Wenzhou Medical University,Wenzhou 325035,China;School of Pharmaceutical Sciences,Hangzhou Medical College,Hangzhou 311399,China;Wenzhou Institute,University of Chinese Academy of Sciences,Wenzhou 325001,China
Discovery of novel MIF inhibitors that attenuate microglial inflammatory activation by structures-based virtual screening and in vitro bioassays
Yu Zhang;Lei Xu;Yao Zhang;Jie Pan;Pu-qing Wang;Sheng Tian;Huan-ting Li;Bo-wen Gao;Ting-jun Hou;Xue-chu Zhen;Long-Tai Zheng-Department of Pharmacy,Hubei Clinical Research Center of Parkinson's disease,Xiangyang Key Laboratory of Movement Disorders,Xiangyang No.1 People'Hospital,Hubei University of Medicine,Xiangyang 441000,China;Institute of Bioinformatics and Medical Engineering,Jiangsu University of Technology,Changzhou 213001,China;Jiangsu Key Laboratory of Neuropsychiatric Diseases and College of Pharmaceutical Sciences,Soochow University,Suzhou 215123,China;School of Pharmacy,Baotou Medical College,Baotou 014060,China;College of Pharmaceutical Sciences,Zhejiang University,Hangzhou 310058,China
GPR84 signaling promotes intestinal mucosal inflammation via enhancing NLRP3 inflammasome activation in macrophages
Qing Zhang;Lin-hai Chen;Hui Yang;You-chen Fang;Si-wei Wang;Min Wang;Qian-ting Yuan;Wei Wu;Yang-ming Zhang;Zhan-ju Liu;Fa-jun Nan;Xin Xie-State Key Laboratory of Drug Research,The National Center for Drug Screening,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;School of Pharmaceutical Science and Technology,Hangzhou Institute for Advanced Study,University of Chinese Academy of Sciences,Hangzhou 310024,China;University of Chinese Academy of Sciences,Beijing 100049,China;Department of Gastroenterology,The Shanghai Tenth People's Hospital,Tongji University,Shanghai 200072,China;Burgeon Therapeutics Co.,Ltd,Shanghai 201203,China;Yantai Key Laboratory of Nanomedicine and Advanced Preparations,Yantai Institute of Materia Medica,Yantai 264000,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。